8-K: VSee Health Sets 2026 Annual Meeting Date
Annual Meeting Announcement
VSee Health, Inc. has announced its 2026 Annual Meeting of Stockholders will be held on August 25, 2026, with July 6, 2026, set as the record date.
Summary
- VSee Health, Inc. has set August 25, 2026, as the date for its 2026 Annual Meeting of Stockholders.
- The record date for determining eligible stockholders to receive notice and vote is July 6, 2026.
- Stockholder proposals intended for inclusion in the proxy materials must be received by July 17, 2026.
- This deadline also applies to proposals for business to be brought before the meeting and for director nominations intended to solicit proxies.
- All proposals should be sent to the Secretary and Chief Financial Officer at the company's principal executive offices.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, primarily containing procedural information regarding the upcoming annual stockholder meeting and associated deadlines.
Risks
- Failure to meet the July 17, 2026 deadline for proposals could result in them not being considered for the 2026 Annual Meeting.
- Stockholder proposals must meet specific SEC requirements to be included in proxy materials.
- Failure to comply with universal proxy rules by the July 17, 2026 deadline could impact director nominations.
Future Outlook
The company will publish additional details regarding the exact time, location, and matters to be voted on at the 2026 Annual Meeting in its proxy statement.
Industry Context
StockSavvy.ai notes that setting annual meeting dates and associated deadlines is a standard procedural requirement for publicly traded companies, particularly those listed on major exchanges like the Nasdaq.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Annual Meeting Date Ratification | The Board of Directors ratified August 25, 2026, as the date for the 2026 Annual Meeting of Stockholders. | 2026-07-06 | Standard corporate governance procedure to set the date for the annual shareholder meeting. |
| Record Date Determination | July 6, 2026, was set as the record date for determining stockholders eligible to receive notice of and vote at the 2026 Annual Meeting. | 2026-07-06 | Establishes the shareholder base eligible to participate in the annual meeting. |
| By-law Compliance | The company is adhering to its amended and restated by-laws regarding stockholder proposals for business to be brought before the meeting. | 2026-07-17 | Ensures that business brought before the meeting meets the company's internal governance requirements. |
Stakeholder Impact
- Shareholders are informed of the date of the annual meeting and the deadlines for submitting proposals and nominations, allowing them to participate in corporate governance.
- The deadlines ensure that the company can prepare and distribute proxy materials in a timely manner, facilitating shareholder voting.
Next Steps
- The company will publish additional details regarding the 2026 Annual Meeting in its proxy statement.
- Stockholders must submit proposals by July 17, 2026, to be considered for the meeting.
Key Dates
| Date | Description |
|---|---|
| 2026-07-06 | Record date for determining stockholders eligible to receive notice of and vote at the 2026 Annual Meeting. |
| 2026-07-06 | Date of the earliest event reported in this Form 8-K. |
| 2026-07-17 | Deadline for receipt of stockholder proposals for inclusion in proxy materials under Rule 14a-8. |
| 2026-07-17 | Deadline for receipt of stockholder proposals for exercising discretionary voting authority under Rule 14a-4(c). |
| 2026-07-17 | Deadline for receipt of notice for business to be brought before the 2026 Annual Meeting by a stockholder. |
| 2026-07-17 | Deadline for stockholders intending to solicit proxies for director nominees to provide notice under Rule 14a-19. |
| 2026-08-25 | Date of the Company's 2026 Annual Meeting of Stockholders. |
| 2026-07-10 | Date of the filing of this Form 8-K. |
Keywords
VSee Health, Annual Meeting, Stockholders, Proxy Statement, Shareholder Proposals, Director Nominations, SEC Filing, Form 8-K
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.